Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway

Tetramethylpyrazine and Astragaloside IV Synergistically Ameliorate Left Ventricular Remodeling and Preserve Cardiac Function in a Rat Myocardial Infarction Model

(2017) Chuying Wang et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation

(2017) Zhiwei Dong et al.   Scientific Reports

Cardiomyocyte A Disintegrin And Metalloproteinase 17 (ADAM17) Is Essential in Post–Myocardial Infarction Repair by Regulating AngiogenesisCLINICAL PERSPECTIVE

(2015) Dong Fan et al.   Circulation-Heart Failure

Astragaloside IV Stimulates Angiogenesis and Increases Nitric Oxide Accumulation via JAK2/STAT3 and ERK1/2 Pathway

(2013) Shi-Guang Wang et al.   MOLECULES

Astragaloside IV Stimulates Angiogenesis and Increases Hypoxia-Inducible Factor-1  Accumulation via Phosphatidylinositol 3-Kinase/Akt Pathway

(2011) L. Zhang et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Epidemiology and risk profile of heart failure

(2010) Anh L. Bui et al.   Nature Reviews Cardiology

Targeting angiogenesis to restore the microcirculation after reperfused MI

(2009) Anja M. van der Laan et al.   Nature Reviews Cardiology

Effects of Astragaloside IV on heart failure in rats

(2009) Zhuanyou Zhao et al.   Chinese Medicine